102.71MMarket Cap-471P/E (TTM)
1.230High1.160Low340.55KVolume1.230Open1.240Pre Close401.78KTurnover0.58%Turnover RatioLossP/E (Static)88.54MShares5.64052wk High0.99P/B68.64MFloat Cap0.98052wk Low--Dividend TTM59.17MShs Float157.980Historical High--Div YieldTTM5.65%Amplitude0.980Historical Low1.179Avg Price1Lot Size
Allakos Stock Forum
SEC announcement
·
01/29 17:30
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2 ...
No comment yet